Novo Nordisk A/S Common Stock (NVO)
Operating Income Growth
-0.49%
TTM · Period ending:
NVO Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-0.49%period ending
Latest reported-0.49%period ending
NVO TTM Operating Income YoY % (26.87% → -0.49%)
Year-over-year change
High-resolution chart · PNG
NVO operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| 97.0889% | |
| 175.0948% | |
| 250.0032% | |
| 246.524% | |
| 64.0549% | |
| 42.1152% | |
| 31.2128% | |
| 17.6363% | |
| 19.4764% | |
| 22.2951% | |
| 34.3125% | |
| 14.5908% | |
| 15.4157% | |
| 28.333% | |
| 11.4641% | |
| 53.3224% | |
| 55.9105% | |
| 15.8533% | |
| 9.0349% | |
| 6.8816% | |
| -21.2708% | |
| -12.2839% | |
| -3.1528% | |
| -30.7828% | |
| -18.7423% | |
| -10.4039% | |
| -0.6672% | |
| 50.2489% | |
| 93.6092% | |
| 90.0029% | |
| 45.3839% | |
| -23.1943% | |
| -41.3573% | |
| -33.9889% | |
| -13.8087% | |
| 30.0815% | |
| 48.8116% | |
| 31.6948% | |
| 37.1199% | |
| 24.5581% | |
| 23.5878% | |
| 35.5307% | |
| -0.7902% | |
| -34.9045% | |
| -35.073% | |
| -37.1806% | |
| 26.203% | |
| 169.8386% | |
| 135.0634% | |
| 158.2731% | |
| 24.968% | |
| -24.6954% | |
| -9.2807% | |
| -28.337% | |
| -0.9038% | |
| 55.6011% | |
| 26.8652% |